Dashboard
Manage Tickers

CTMXCytomX Therapeutics, Inc.

Nasdaq cytomx.com


$ 2.04 $ -2.15 (-51.31 %)    

Thursday, 09-May-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 2.04
$ 2.97
$ 0.00 x 0
$ 0.00 x 0
$ 2.01 - $ 3.08
$ 1.04 - $ 5.85
41,562,499
na
168.57M
$ 1.07
$ 10.20
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-11-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-27-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-07-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-07-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 03-02-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 03-07-2016 12-31-2015 10-K
35 11-23-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

analysts-varied-perspectives-on-cytomxs-cx-904-cancer-study-safety-profile-but-caution-in-pancreatic-cancer
Analysts' Varied Perspectives On CytomX's ...
05/09/2024 18:59:21

Initial data from CytomX Therapeutics' CX-904 Phase 1a study shows safety and anti-cancer activity in heavily pretreated pa...

gold-moves-higher-roblox-issues-weak-outlook
Gold Moves Higher; Roblox Issues Weak Outlook
05/09/2024 18:30:25

why-duolingo-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Duolingo Shares Are Trading Lower By A...
05/09/2024 17:57:05

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 16:31:09

dow-jumps-over-150-points-us-foods-posts-upbeat-earnings
Dow Jumps Over 150 Points; US Foods Posts ...
05/09/2024 16:01:29

bmo-capital-maintains-market-perform-on-cytomx-therapeutics-raises-price-target-to-359
BMO Capital Maintains Market Perform on Cy...
05/09/2024 14:54:24

BMO Capital analyst Etzer Darout maintains CytomX Therapeutics (NASDAQ:CTMX) with a Market Perform and raises the price targ...

hc-wainwright--co-reiterates-neutral-on-cytomx-therapeutics
HC Wainwright & Co. Reiterates Neutral on ...
05/09/2024 14:08:49

HC Wainwright & Co. analyst Mitchell Kapoor reiterates CytomX Therapeutics (NASDAQ:CTMX) with a Neutral.

wedbush-upgrades-cytomx-therapeutics-to-outperform-raises-price-target-to-8
Wedbush Upgrades CytomX Therapeutics to Ou...
05/09/2024 13:08:50

Wedbush analyst Robert Driscoll upgrades CytomX Therapeutics (NASDAQ:CTMX) from Neutral to Outperform and raises the price t...

why-applovin-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket
Why AppLovin Shares Are Trading Higher By ...
05/09/2024 12:13:28

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

cytomx-therapeutics-q1-2024-gaap-eps-017-beats-006-estimate-sales-41463m-beat-21434m-estimate
CytomX Therapeutics Q1 2024 GAAP EPS $0.17...
05/08/2024 21:01:06

CytomX Therapeutics (NASDAQ:CTMX) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $...

cytomx-therapeutics-announces-initial-phase-1a-dose-escalation-data-for-monotherapy-cx-904-demonstrated-favorable-safety-profile-says-2-of-6-patients-confirmed-partial-response-and-all-6-patients-with-disease-control
CytomX Therapeutics Announces Initial Phas...
05/08/2024 20:50:23

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 20:31:13

Core News & Articles
CytomX Therapeutics Announces Clinical Col...
05/07/2024 21:26:01

- CX-801 is a dually masked, conditionally activated IFNα2b cytokine designed using the CytomX Probody® Therapeutic Platform

cytomx-therapeutics-shares-are-trading-higher-after-jefferies-upgraded-the-stock-from-hold-to-buy-and-raised-its-price-target-from-25-to-8
CytomX Therapeutics shares are trading hig...
05/06/2024 12:37:44

jefferies-upgrades-cytomx-therapeutics-to-buy-raises-price-target-to-8
Jefferies Upgrades CytomX Therapeutics to ...
05/06/2024 12:35:04

Jefferies analyst Roger Song upgrades CytomX Therapeutics (NASDAQ:CTMX) from Hold to Buy and raises the price target from $2...

etsy-reports-downbeat-earnings-joins-fastly-doordash-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Etsy Reports Downbeat Earnings, Joins Fast...
05/02/2024 12:17:25

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 12:06:54

why-aspen-aerogels-shares-are-trading-higher-by-26-here-are-20-stocks-moving-premarket
Why Aspen Aerogels Shares Are Trading High...
05/02/2024 09:43:31

dow-jumps-200-points-following-fed-decision-pfizer-earnings-top-estimates
Dow Jumps 200 Points Following Fed Decisio...
05/01/2024 18:32:12

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION